Your bones are your bodys framework-and for many, the bone-building drugs bisphosphonates ensure a sound foundation against the impact of osteoporosis. Bisphosphonates, including the oral drugs alendronate (Fosamax), risedronate (Actonel) and ibandronate (Boniva), and the intravenously (IV) administered zoledronic acid (Reclast), have been shown to reduce the risk for fracture and improve bone strength. But, as the saying goes, there can be too much of a good thing.
To continue reading this article or issue you must be a paid subscriber
Subscribe to Arthritis Advisor
Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In |
Forgot your password? |
Activate Web Access
